Hancom Lifecare Statistics
Total Valuation
Hancom Lifecare has a market cap or net worth of KRW 70.02 billion. The enterprise value is 34.60 billion.
| Market Cap | 70.02B |
| Enterprise Value | 34.60B |
Important Dates
The last earnings date was Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Hancom Lifecare has 27.67 million shares outstanding. The number of shares has increased by 2.76% in one year.
| Current Share Class | 27.67M |
| Shares Outstanding | 27.67M |
| Shares Change (YoY) | +2.76% |
| Shares Change (QoQ) | -9.99% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 14.55M |
Valuation Ratios
The trailing PE ratio is 31.88 and the forward PE ratio is 9.56.
| PE Ratio | 31.88 |
| Forward PE | 9.56 |
| PS Ratio | 0.79 |
| PB Ratio | 0.52 |
| P/TBV Ratio | 0.53 |
| P/FCF Ratio | 4.37 |
| P/OCF Ratio | 3.77 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.08, with an EV/FCF ratio of 2.16.
| EV / Earnings | 15.24 |
| EV / Sales | 0.39 |
| EV / EBITDA | 4.08 |
| EV / EBIT | 9.56 |
| EV / FCF | 2.16 |
Financial Position
The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.00.
| Current Ratio | 1.98 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.03 |
| Interest Coverage | 185.11 |
Financial Efficiency
Return on equity (ROE) is 1.69% and return on invested capital (ROIC) is 1.66%.
| Return on Equity (ROE) | 1.69% |
| Return on Assets (ROA) | 1.13% |
| Return on Invested Capital (ROIC) | 1.66% |
| Return on Capital Employed (ROCE) | 2.66% |
| Revenue Per Employee | 440.86M |
| Profits Per Employee | 11.30M |
| Employee Count | 201 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 1.41 |
Taxes
| Income Tax | -347.48M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.74% in the last 52 weeks. The beta is 0.15, so Hancom Lifecare's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | -29.74% |
| 50-Day Moving Average | 2,662.40 |
| 200-Day Moving Average | 2,985.45 |
| Relative Strength Index (RSI) | 42.30 |
| Average Volume (20 Days) | 95,959 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hancom Lifecare had revenue of KRW 88.61 billion and earned 2.27 billion in profits. Earnings per share was 79.37.
| Revenue | 88.61B |
| Gross Profit | 23.98B |
| Operating Income | 3.62B |
| Pretax Income | 1.91B |
| Net Income | 2.27B |
| EBITDA | 8.49B |
| EBIT | 3.62B |
| Earnings Per Share (EPS) | 79.37 |
Balance Sheet
The company has 36.48 billion in cash and 433.66 million in debt, giving a net cash position of 36.04 billion or 1,302.35 per share.
| Cash & Cash Equivalents | 36.48B |
| Total Debt | 433.66M |
| Net Cash | 36.04B |
| Net Cash Per Share | 1,302.35 |
| Equity (Book Value) | 135.10B |
| Book Value Per Share | 4,860.55 |
| Working Capital | 61.49B |
Cash Flow
In the last 12 months, operating cash flow was 18.57 billion and capital expenditures -2.53 billion, giving a free cash flow of 16.04 billion.
| Operating Cash Flow | 18.57B |
| Capital Expenditures | -2.53B |
| Free Cash Flow | 16.04B |
| FCF Per Share | 579.49 |
Margins
Gross margin is 27.06%, with operating and profit margins of 4.08% and 2.56%.
| Gross Margin | 27.06% |
| Operating Margin | 4.08% |
| Pretax Margin | 2.16% |
| Profit Margin | 2.56% |
| EBITDA Margin | 9.58% |
| EBIT Margin | 4.08% |
| FCF Margin | 18.10% |
Dividends & Yields
Hancom Lifecare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.76% |
| Shareholder Yield | -2.76% |
| Earnings Yield | 3.24% |
| FCF Yield | 22.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Hancom Lifecare has an Altman Z-Score of 2.78 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.78 |
| Piotroski F-Score | 6 |